Similar to SPTLC1 ALS variants, this SPTLC2 ALS variant also results in overproduction of canonical sphingolipids in patient derived fibroblasts without increasing 1-deoxySL production rates (figure 4B,C). This evidence concerns the gene SPTLC2 and amyotrophic lateral sclerosis.